The effect of recombinant adeno-associated virus-adiponectin (rAAV2/1-Acrp30) on glycolipid dysmetabolism and liver morphology in diabetic rats

General and Comparative Endocrinology

Volumn 206, Issue , 2014, Pages 1-7

  Long, Wen ^a   Hui Ju, Zhong ^a   Fan, Zhang ^a   Jing, Wang ^a   Qiong, Li ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Adiponectin; I B ; Non alcoholic fatty liver; Nuclear factor B; Type 2 diabetes mellitus

Indexed keywords

ADIPONECTIN; GLYCOLIPID; HIGH DENSITY LIPOPROTEIN; I KAPPA B ALPHA; PARVOVIRUS VECTOR; TRANSCRIPTION FACTOR RELA; ADIPOQ PROTEIN, RAT; GLUCOSE BLOOD LEVEL; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG LIVER LEVEL; DRUG MECHANISM; DRUG RESEARCH; GLUCOSE BLOOD LEVEL; LIVER DISEASE; LIVER STRUCTURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; ADIPOCYTE; ANIMAL; APOPTOSIS; DEPENDOPARVOVIRUS; ENZYME IMMUNOASSAY; EXPERIMENTAL DIABETES MELLITUS; GENETICS; INSULIN RESISTANCE; LIVER; METABOLISM; NICK END LABELING; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOLOGY; WISTAR RAT;

ADIPOCYTES; ADIPONECTIN; ANIMALS; APOPTOSIS; BLOOD GLUCOSE; DEPENDOVIRUS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; GLYCOLIPIDS; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; INSULIN RESISTANCE; LIVER; MALE; OBESITY; RATS; RATS, WISTAR; RECOMBINANT PROTEINS;

EID: 84906557399     PISSN: 00166480     EISSN: 10956840     Source Type: Journal    
DOI: 10.1016/j.ygcen.2014.07.003     Document Type: Article

References (28)

1. Angulo P., Lindor K.D. Non-alcoholic fatty liver disease. J. Gastro-enterol. Hepatol. 2002, 17:186-190.
2. Bahjat F.R., Dharnidharka V.R. Reduced susceptibility of nonobese diabetic mice to TNF-a and D-galactosamine-mediated hepatocellular apoptosis and lethality. J. Chem. Immunol. 2000, 165:6559-6567.
3. Berg A.H., Combs T.P., Du X., et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 2001, 7(8):947-953.
4. Briohny W.S., Adams L.A. Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat. Rev. Endocrinol. 2011, 7(8):456-465.
5. Cnop M., Havel P.J., Utzschneider K.M., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003, 46(4):459-469.
6. Cusi K. Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Curr. Opin. Endocrinol. Diabetes Obes. 2009, 16(2):141-149.
7. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. J. Nat. Rev. Immunol. 2011, 11(2):98-107.
8. Furukawa K., Hori M., Ouchi N., et al. Adiponectin down-regulates acylcoenzyme A: cholesterol acyltransferase-1 in cultured human monocytederived macrophages. Biochem. Biophys. Res. Commun. 2004, 317:831-836.
9. Motoshima Hiroyuki, Xiangdong Wu, Mahadev Kalyankar, Goldstein Barry J. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activityin endothelial cells treated with oxidized LDL. Biochem. Biophys. Res. Commun. 2004, 315:264-271.
10. Hotta K., Funahashi T., Arita Y., et al. Plasma concentrations of a novel, adipose specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000, 20(6):1595-1599.
11. Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
12. Kim H.-S., Jo J., Lim J.E., et al. Adiponectin as predictor for diabetes among pre-diabetic groups. Endocrine 2013, 10.1007/s12020-013-9890-5.
13. Leite N.C., Salles G.F., Araujo A.L., et al. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. J. Liver Int. 2009, 29(1):113-119.
14. Lewis J.R., Mohanty SIL Nonalcoholic fatty liver disease: a review and update. J. Dig. Dis. Sci. 2010, 55(3):560-578.
15. Loiler S.A., Conlon T.J., Song S. Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver. Gene Ther. 2003, 10(18):1551-1558.
16. Li Z., Yang S., Lin H., et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003, 37:343-350.
17. Ma H., Gomez V., Lu L., et al. Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 2009, 24(2):173-175.
18. Maeda K., Okubo K., Shimomura I., et al. CDNA cloning and expression of a novel adipose specific collagen-like factor, apM1(adipose most abundant gene transcript 1). Biochem. Biophys. Res. Commun. 1996, 221:286-289.
19. Maeda N., Shimomura L., Kishida K., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 2002, 8:731-737.
20. Bergman Michael. Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus. Endocrine 2013, 43:504-513.
21. Michael J.M., Ghoah S. Signal transduction through NF-rB. Immunol. Today 1998, 19(2):80-88.
22. Pardo M., Roca-Rivada Arturo, Seoane L.M. Obesidomics: contribution of adipose tissue secretome analysis to obesity research. Endocrine 2012, 41:374-383.
23. Scorletti E., Calder P.C., Byrne C.D. Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments. Endocrine 2011, 40:332-343.
24. Stanislav S., Aslanidi G., Tennant M., et al. Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc. Natl. Acad. Sci. U.S.A. 2003, 100(24):14217-14222.
25. Stephen Susan. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004, 27(2):553-591.
26. Tataranini P.A., Ortega E. A burning question: does an adipokine induced activation of the immune system mediate the effect of over nutrition on type 2 diabetes?. Diabetes 2005, 54(4):917-927.
27. Taylor C.T., Cummins E.P. The role of NF-kappa B in hypoxia-induced gene expression. Ann. N. Y. Acad. Sci. 2009, 1177:178-184.
28. Xu A., Wang Y., Keshaw H., et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Invest. 2003, 112:91-100.